CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
In this Labs in Court Weekly Roundup, all the main health care-related cases involved False Claims Act allegations or charges.
The company has successfully completed clinical trials in Israel on more than 300 women and is applying for CE marking and FDA approval.
New research shows cancer screening prevalence declined in 2020 compared to 2018, though not for all cancer types studied.
A glitch in the local run management software may open the door to hacking, agency says.
White House releases an update on the progress of the initiative to provide equitable access to COVID-19 testing and treatments in the US.
OIG report finds that $8 million of $40 million in claims made by such suppliers in a recent audit did not meet Medicare requirements.
NY federal court ruling sheds light on what constitutes “remuneration” banned by the Anti-Kickback Statute.
Partnership will make use of Illumina’s capabilities and expertise in large-scale genomic sequencing and quickly generate high-quality data.
Lawmakers blame pharmacy benefit managers for high drug prices, introducing a bill to prevent what they term unfair practices.
HHS pulls the plug on a Trump rule requiring regulations to expire automatically after 10 years.